See More
See Faster
See In Situ
Through ultrasensitive InSituPlex® assays and advanced, AI-driven spatial analysis, Ultivue empowers scientists developing precision cancer therapies to generate quantitative, high confidence insights in just a fraction of the time.
“At Ultivue, we power insights through AI-driven, quantitative spatial proteomics. We are inspired by the scientists we serve in translational and clinical research, mutually committed to realizing the full promise of precision medicine for cancer patients.“
Rob Carson, President and CEO
Revealing the true state of cancer
Revealing the true state of cancer
What if you could answer the following?
Can I identify markers, phenotypes and spatial interactions which can best distinguish different patient groups?
Can I segment samples into treatment groups and learn how the tumor responds to treatment?
How do I compare tissues pre and post treatment to better understand drug action?
Can I reduce assay complexity to move into clinical practice?
How do I look for the more relevant assay design for my study?
Can I analyze drug treatment data to robustly determine key phenotypes that predict success?
Can I survey across multiple tumor types to find those with the most treatment potential?
To explore how quantitative spatial profiling could expand the depth and clarity of information and insights available for your research, please get in touch.
On-Demand Webinar
Unraveling the Tumor Microenvironment Using Custom mIF Panels & Spatial Tissue Analysis
Watch Now